Tumor Suppressor CYLD Regulates Acute Lung Injury in Lethal Streptococcus pneumoniae Infections
- 1 August 2007
- Vol. 27 (2) , 349-360
- https://doi.org/10.1016/j.immuni.2007.07.011
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumoniaBlood, 2006
- The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal DiseaseInfection and Immunity, 2005
- The role of hepatic type 1 plasminogen activator inhibitor (PAI‐1) during murine hemorrhagic shock†Hepatology, 2005
- Oxidised‐HDL3 induces the expression of PAI‐1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilizationBritish Journal of Haematology, 2004
- Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumoniaBlood, 2003
- Transforming Growth Factor-β-Smad Signaling Pathway Negatively Regulates Nontypeable Haemophilus influenzae-induced MUC5AC Mucin Transcription via Mitogen-activated Protein Kinase (MAPK) Phosphatase-1-dependent Inhibition of p38 MAPKJournal of Biological Chemistry, 2003
- Novel Cytoplasmic Proteins of Nontypeable Haemophilus influenzae Up-regulate Human MUC5AC Mucin Transcription via a Positive p38 Mitogen-activated Protein Kinase Pathway and a Negative Phosphoinositide 3-Kinase-Akt PathwayJournal of Biological Chemistry, 2002
- Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosisBritish Journal of Pharmacology, 1998
- Pathogenesis of Pneumococcal InfectionNew England Journal of Medicine, 1995
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989